You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis

  • Technology appraisal guidance
  • Reference number: TA254
  • Published:  25 April 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendations coming out of this guidance

  • NICE recommends the development of patient registries for multiple sclerosis to capture long-term treatment-related outcomes.

  • NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts, which uses the best available evidence (including experience to date from the risk-sharing scheme) and includes all currently available treatments.

Back to top